GB8716323D0 - Bromocriptine - Google Patents

Bromocriptine

Info

Publication number
GB8716323D0
GB8716323D0 GB878716323A GB8716323A GB8716323D0 GB 8716323 D0 GB8716323 D0 GB 8716323D0 GB 878716323 A GB878716323 A GB 878716323A GB 8716323 A GB8716323 A GB 8716323A GB 8716323 D0 GB8716323 D0 GB 8716323D0
Authority
GB
United Kingdom
Prior art keywords
bromocriptine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB878716323A
Other versions
GB2192541B (en
GB2192541A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8716323D0 publication Critical patent/GB8716323D0/en
Publication of GB2192541A publication Critical patent/GB2192541A/en
Application granted granted Critical
Publication of GB2192541B publication Critical patent/GB2192541B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB8716323A 1986-07-14 1987-07-10 New use of bromocriptine Expired - Lifetime GB2192541B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88511086A 1986-07-14 1986-07-14

Publications (3)

Publication Number Publication Date
GB8716323D0 true GB8716323D0 (en) 1987-08-19
GB2192541A GB2192541A (en) 1988-01-20
GB2192541B GB2192541B (en) 1990-05-02

Family

ID=25386156

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8716323A Expired - Lifetime GB2192541B (en) 1986-07-14 1987-07-10 New use of bromocriptine

Country Status (13)

Country Link
JP (1) JPS6323817A (en)
KR (1) KR880001292A (en)
AU (1) AU602154B2 (en)
CH (1) CH672987A5 (en)
DE (1) DE3722383A1 (en)
DK (1) DK363887A (en)
FR (1) FR2601245A1 (en)
GB (1) GB2192541B (en)
IT (1) IT1224222B (en)
NL (1) NL8701631A (en)
PH (1) PH24525A (en)
SE (1) SE8702843L (en)
ZA (1) ZA875145B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814521A1 (en) * 1987-05-07 1988-11-17 Sandoz Ag NEW APPLICATION OF DOPAMINE RECEPTOR AGONISTS
EP0327040A3 (en) * 1988-02-05 1990-11-28 Predrag Dr.Sc. Sikiric Use of dopamine and/or dopamine agonists to prepare a medicine for the treatment of the digestive tract
US5716933A (en) * 1988-05-10 1998-02-10 Louisiana State University And Agricultural And Mechanical College Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates
US6004972A (en) * 1988-05-10 1999-12-21 The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of type II diabetes
US5468755A (en) * 1988-05-10 1995-11-21 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of Type II diabetes
US5744477A (en) * 1988-05-10 1998-04-28 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for treatment of obesity using prolactin modulators and diet
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US5700800A (en) * 1988-05-10 1997-12-23 Ergo Science Incorporated Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
US5585347A (en) * 1988-05-10 1996-12-17 Ergo Science Incorporated Methods for the determination and adjustment of prolactin daily rhythms
US5830895A (en) * 1988-05-10 1998-11-03 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods for the determination and adjustment of prolactin daily rhythms
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
WO1993012793A1 (en) * 1991-12-23 1993-07-08 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College A therapeutic process for the treatment of the pathologies of type ii diabetes
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5626860A (en) * 1995-06-07 1997-05-06 The Board Of Supervisors Of Louisana State And Agricultural And Mechanical College Method for regulating metabolism with dopamine beta hydroxylase inhibitors
US5714519A (en) * 1995-06-07 1998-02-03 Ergo Science Incorporated Method for regulating glucose metabolism
US20010016582A1 (en) 1997-04-28 2001-08-23 Anthony H. Cincotta Method and composition for the treatment of lipid and glucose metabolism disorders
PT2091537E (en) 2006-11-23 2013-08-29 Sinoxa Pharma Gmbh Pharmaceutical compositions for the treatment of capillary arteriopathy
DK3445362T3 (en) * 2016-04-20 2021-10-11 Veroscience Llc Composition and method of treatment of metabolic diseases
EP4233913A3 (en) 2017-10-18 2023-10-18 VeroScience LLC Improved bromocriptine formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (en) * 1968-05-31 1971-05-15 Sandoz Ag Process for the preparation of 2-bromo-a-ergocryptine
CH666406A5 (en) * 1984-02-29 1988-07-29 Sandoz Ag METHOD FOR PRODUCING microcapsules BROMOKRIPTINMESYLAT AS PHARMACOLOGICAL ACTIVE INCLUDED.
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions

Also Published As

Publication number Publication date
CH672987A5 (en) 1990-01-31
ZA875145B (en) 1989-02-22
SE8702843L (en) 1988-01-15
KR880001292A (en) 1988-04-22
IT8748160A0 (en) 1987-07-10
SE8702843D0 (en) 1987-07-13
NL8701631A (en) 1988-02-01
DK363887D0 (en) 1987-07-13
IT1224222B (en) 1990-09-26
FR2601245A1 (en) 1988-01-15
DE3722383A1 (en) 1988-01-28
GB2192541B (en) 1990-05-02
JPS6323817A (en) 1988-02-01
AU7558787A (en) 1988-01-21
GB2192541A (en) 1988-01-20
DK363887A (en) 1988-01-15
PH24525A (en) 1990-07-18
AU602154B2 (en) 1990-10-04

Similar Documents

Publication Publication Date Title
GB8716323D0 (en) Bromocriptine
CS535786A1 (en) Parfemovane vyrobky z termoplastu
PL266931A1 (en) Weedicidal specific
CS115586A1 (en) Zpusob izolace opiovych alkaloidu z opia
CS108986A1 (en) Regenerace platiny z odpadu
CS709886A1 (en) Zusob vyro desek z austenitickych oceli
CS535986A1 (en) Zpusob pripravy detektoru ionizujiciho zareni z monokrystalu hlinitoyttriteho granatu nebo perovskitu
CS649486A1 (en) Sposob izolacie fytosterolov z taloveho oleja
GB8626797D0 (en) Carrying holdall
CS987386A1 (en) Samosberaci vuz posecenych travin z melioracnich kanalu
CS274886A1 (en) Slozeny detektor z monokrystalu vizmutgermanatu
CS332086A1 (en) Sposob odstranovania najmae mikrotrhlin z povrchov kovovych materialov
CS318586A1 (en) Zpusob odstranovani chlorovanyc uhlovodiku z vody
CS920186A1 (en) Sposob vyroby bielkovinoveho pripravku z jatocnej krvi
CS919986A1 (en) Zpusob zpracovani pasu z cinovych bronzu
CS3386A1 (en) Podzemna drenazna sachta z plastov
CS903186A1 (en) Zpusob odstranovani manganu z vody
CS358186A1 (en) Zpusob zpracovani odpadni vody z vyroby benzylalkoholu
CS373886A1 (en) Zpusob odstranovani oxidu uhliku z technickeho vodiku metanaci
CS670686A1 (en) Zpusob zvyseni opticke jakosti vyrobku z monokrystalu niobicananu lithneho
CS653886A1 (en) Devarka z umele hmoty
CS799586A1 (en) Viceucelovy uzaver z plasticke hmoty
CS836086A1 (en) Zpusob zvyseni ucinnosti sorpce uranu z kyselych rmutu
CS814486A1 (en) Zpusob tepelnehozpracovani odlitku z nizkouhlikove antikorozni oceli
CS611686A1 (en) Sposob spracovania odpadnych produktov z vyroby pentaerytritolu

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee